Medicare Enrolled
Dr. Thomas Chengot, D.O.
Interventional Cardiology · Amityville, NY
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chengot from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chengot?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chengot
Dr. Thomas Chengot is an interventional cardiology specialist in Amityville, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Chengot performed 5,651 Medicare services across 3,491 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chengot received a total of $34,196 from 63 pharmaceutical and/or device companies across 869 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chengot is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 5% volume in NY
$34,196 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,651
Medicare services
Top 5% in NY for interventional cardiology
3,491
Unique beneficiaries
$188
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~332 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,320 | $43 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
868 | $113 | $161 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 646 | $385 | $481 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
335 | $66 | $400 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
330 | $31 | $100 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
323 | $1,258 | $2,500 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
322 | $126 | $250 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
205 | $183 | $550 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
177 | $74 | $130 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
153 | $13 | $93 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
142 | $12 | $56 |
| Cardiac catheterization | 117 | $238 | $1,000 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
79 | $122 | $300 |
| Additional heart vessel ultrasound evaluation An additional ultrasound assessment of a specific heart blood vessel or graft, including radiologist review. |
75 | $74 | $150 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
68 | $183 | $597 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
63 | $514 | $925 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
63 | $93 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
63 | $81 | $129 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
53 | $14 | $115 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
50 | $8 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $144 | $292 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
26 | $165 | $650 |
| Injection, furosemide, up to 20 mg | 26 | $0 | $5 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 21 | $323 | $1,200 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
20 | $223 | $650 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $154 | $229 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
14 | $7 | $70 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
14 | $21 | $150 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
13 | $232 | $596 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
13 | $12 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.1% high complexity
40.4% medium
46.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,196
Total received (2018-2024)
Avg $4,885/year across 7 years
Top 19% in NY for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
869
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$33,928 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$268 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,551
2023
$5,313
2022
$4,316
2021
$5,639
2020
$3,473
2019
$7,507
2018
$4,398
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$564
Medtronic, Inc.
$473
CVRx, Inc.
$374
ABIOMED
$247
Novartis Pharmaceuticals Corporation
$188
Boston Scientific Corporation
$188
Amgen Inc.
$166
Intra-Sana Laboratories
$147
Actelion Pharmaceuticals US, Inc.
$139
Novo Nordisk Inc
$138
Penumbra, Inc.
$131
Daiichi Sankyo Inc.
$122
E.R. Squibb & Sons, L.L.C.
$83
Edwards Lifesciences Corporation
$77
Bayer Healthcare Pharmaceuticals Inc.
$66
Esperion Therapeutics, Inc.
$61
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$57
PFIZER INC.
$51
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
SCPHARMACEUTICALS INC.
$45
Kiniksa Pharmaceuticals International, plc
$38
CARDIVA MEDICAL, INC.
$29
180 Medical, Inc.
$23
Tactile Systems Technology Inc
$23
Acorda Therapeutics, Inc
$21
HEARTFLOW, INC.
$18
Merck Sharp & Dohme LLC
$17
Dexcom, Inc.
$15
Top 3 companies account for 39.7% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$6,456
Medtronic Vascular, Inc.
$5,383
Medtronic, Inc.
$2,389
Inari Medical, Inc.
$1,974
Edwards Lifesciences Corporation
$1,827
Janssen Pharmaceuticals, Inc
$1,746
Medical Device Business Services, Inc.
$1,182
ABIOMED
$1,106
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,102
Novartis Pharmaceuticals Corporation
$1,095
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$906
Actelion Pharmaceuticals US, Inc.
$778
Amgen Inc.
$684
AstraZeneca Pharmaceuticals LP
$612
Boston Scientific Corporation
$542
E.R. Squibb & Sons, L.L.C.
$530
Novo Nordisk Inc
$515
PFIZER INC.
$490
MEDICOMP INC
$437
Amarin Pharma Inc.
$411
CVRx, Inc.
$374
SANOFI-AVENTIS U.S. LLC
$356
BOSTON SCIENTIFIC CORPORATION
$303
Esperion Therapeutics, Inc.
$263
Daiichi Sankyo Inc.
$259
ARBOR PHARMACEUTICALS, INC.
$236
Lundbeck LLC
$168
Regeneron Healthcare Solutions, Inc.
$165
Intra-Sana Laboratories
$147
Bayer Healthcare Pharmaceuticals Inc.
$133
Penumbra, Inc.
$131
Chiesi USA, Inc.
$129
Janssen Scientific Affairs, LLC
$124
Bayer HealthCare Pharmaceuticals Inc.
$110
Kiniksa Pharmaceuticals, Ltd.
$100
Merck Sharp & Dohme LLC
$98
Bardy Diagnostics, Inc.
$82
Gilead Sciences, Inc.
$79
Kowa Pharmaceuticals America, Inc.
$73
iRhythm Technologies, Inc.
$71
CHIESI USA, INC.
$53
ShockWave Medical, Inc
$51
SCPHARMACEUTICALS INC.
$45
HeartFlow, Inc.
$39
Kiniksa Pharmaceuticals International, plc
$38
Arbor Pharmaceuticals, Inc.
$36
Allergan Inc.
$35
Cardiovascular Systems Inc.
$29
CARDIVA MEDICAL, INC.
$29
Baxter Healthcare
$28
Kestra Medical Technology Services, Inc.
$24
Lexicon Pharmaceuticals, Inc.
$24
Terumo Medical Corporation
$24
180 Medical, Inc.
$23
Tactile Systems Technology Inc
$23
Acorda Therapeutics, Inc
$21
Althera Pharmaceuticals LLC
$19
ARALEZ PHARMACEUTICALS US INC.
$19
HEARTFLOW, INC.
$18
InfoBionic, Inc
$16
Dexcom, Inc.
$15
Shockwave Medical, Inc
$13
Medicure Pharma Inc.
$10
Top 3 companies account for 41.6% of all-time payments
Associated products mentioned in payments ›
3F · AMPLATZER · ANGIO-SEAL · AVVIGO Guidance System · Adempas · Allure CRT Pacemaker · Arcalyst · Asahi Fielder coronary guide wire · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CLEVIPREX · CLEVIPREX 25MG/50ML · CLEVIPREX 50MG/100ML · CLOSUREFAST · COREVALVE EVOLUT R · CardioMEMS HF System · Carnation Ambulatory Monitor · Carto 3 System · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DARZALEX · DRAGONFLY OPSTAR · Dexcom G6 Transmitter · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EKOSONIC · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · FlowTriever · HI-TORQUE PILOT · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Hillrom - Cardiac Ambulatory Monitor · I-STAT · INBRIJA · INJECTAFER · INVOKANA · Impella · Indigo System · Inpefa · JARDIANCE · JOT DX · KENGREAL · Kerendia · LEQVIO · LINQ II · LIVALO · Letairis · LifeVest · Livalo · MEDI · MINI TREK · MITRACLIP · MOSAIC · MULTAQ · Micra · Mitra Clip system · MitraClip System · MoMe Kardia · Mosaic · NC TREK NEO · NEXLETOL · NORTHERA · OPDIVO · OPSUMIT · OPSUMIT MACITENTAN · OPTIS · Optis Coronary Imaging System · Ozempic · PCI Optimization · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRESSUREWIRE · Perclose ProGlide suture mediated closure system · PressureWire FFR · RELTONE 200 MG · ROTAPRO · Ranexa · Repatha · Resolute · Roszet · Rybelsus · S · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SUPERA · SYMPLICITY G3 · Saxenda · TELEPATCH CARDIAC MONITOR · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · ULTREON · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · Verquvo · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XIENCE SIERRA · XIENCE SKYPOINT · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · Xience V coronary stent system · ZIO XT Patch · ZONTIVITY · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
48
Per 100K population
3.1
County median income
$128,329
Nearest hospital
BRUNSWICK HOSPITAL CENTER, INC.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chengot is a cardiac imaging specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement in the top 19% of NY peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chengot experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Chengot performed 1,320 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chengot receive payments from pharmaceutical companies?
Yes. Dr. Chengot received a total of $34,196 from 63 companies across 869 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chengot's costs compare to other interventional cardiologists in Amityville?
Dr. Chengot's average Medicare payment per service is $188. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chengot) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Amityville
Browse interventional cardiologists in Amityville ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in NY
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in NY
Which NY interventional cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology